These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28167267)

  • 21. The complete sequence of the group-specific antigen, VP7, of African horsesickness disease virus serotype 4 reveals a close relationship to bluetongue virus.
    Roy P; Hirasawa T; Fernandez M; Blinov VM; Sanchez-Vixcain Rodrique JM
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1237-41. PubMed ID: 1646273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional dissection of the major structural protein of bluetongue virus: identification of key residues within VP7 essential for capsid assembly.
    Limn CK; Staeuber N; Monastyrskaya K; Gouet P; Roy P
    J Virol; 2000 Sep; 74(18):8658-69. PubMed ID: 10954567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plant expression systems as an economical alternative for the production of iELISA coating antigen AHSV VP7.
    Fearon SH; Dennis SJ; Hitzeroth II; Rybicki EP; Meyers AE
    N Biotechnol; 2022 May; 68():48-56. PubMed ID: 35114407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV).
    van Rijn PA; van de Water SG; Feenstra F; van Gennip RG
    Virol J; 2016 Jul; 13():119. PubMed ID: 27368544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
    van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
    J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).
    Chiam R; Sharp E; Maan S; Rao S; Mertens P; Blacklaws B; Davis-Poynter N; Wood J; Castillo-Olivares J
    PLoS One; 2009 Jun; 4(6):e5997. PubMed ID: 19543394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VP7 from African horse sickness virus serotype 9 protects mice against a lethal, heterologous serotype challenge.
    Wade-Evans AM; Pullen L; Hamblin C; O'Hara RS; Burroughs JN; Mertens PP
    Arch Virol Suppl; 1998; 14():211-9. PubMed ID: 9785508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural insight into African horsesickness virus infection.
    Manole V; Laurinmäki P; Van Wyngaardt W; Potgieter CA; Wright IM; Venter GJ; van Dijk AA; Sewell BT; Butcher SJ
    J Virol; 2012 Aug; 86(15):7858-66. PubMed ID: 22593166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular production of African horsesickness virus core-like particles by expression of the two major core proteins, VP3 and VP7, in insect cells.
    Maree S; Durbach S; Huismans H
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():333-7. PubMed ID: 9472617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing of African horse sickness virus VP7 protein expression in cultured cells by RNA interference.
    Stassen L; Huismans H; Theron J
    Virus Genes; 2007 Dec; 35(3):777-83. PubMed ID: 17851744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An atomic model of the outer layer of the bluetongue virus core derived from X-ray crystallography and electron cryomicroscopy.
    Grimes JM; Jakana J; Ghosh M; Basak AK; Roy P; Chiu W; Stuart DI; Prasad BV
    Structure; 1997 Jul; 5(7):885-93. PubMed ID: 9261080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Conserved, Computationally Predicted Epitope Regions for VP5 and VP7 Across three Orbiviruses.
    Russell BL; Parbhoo N; Gildenhuys S
    Bioinform Biol Insights; 2018; 12():1177932218755348. PubMed ID: 29434468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of empty african horse sickness virus particles.
    Maree S; Maree FF; Putterill JF; de Beer TAP; Huismans H; Theron J
    Virus Res; 2016 Feb; 213():184-194. PubMed ID: 26686484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New generation of African horse sickness virus vaccines based on structural and molecular studies of the virus particles.
    Roy P; Sutton G
    Arch Virol Suppl; 1998; 14():177-202. PubMed ID: 9785506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral and cell-mediated immune responses to plant-produced African horse sickness virus VP7 quasi-crystals.
    Fearon SH; Dennis SJ; Hitzeroth II; Rybicki EP; Meyers AE
    Virus Res; 2021 Mar; 294():198284. PubMed ID: 33421520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and characterization of the major group-specific core antigen VP7 of bluetongue virus synthesized by a recombinant baculovirus.
    Oldfield S; Adachi A; Urakawa T; Hirasawa T; Roy P
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2649-56. PubMed ID: 2174958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of domain-switching and site-directed mutagenesis on the properties and functions of the VP7 proteins of two orbiviruses.
    Monastyrskaya K; Staeuber N; Sutton G; Roy P
    Virology; 1997 Oct; 237(2):217-27. PubMed ID: 9356334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of African horse sickness virus VP7 antigen, synthesised in bacteria, and anti-VP7 monoclonal antibodies in a competitive ELISA.
    Wade-Evans AM; Woolhouse T; O'Hara R; Hamblin C
    J Virol Methods; 1993 Dec; 45(2):179-88. PubMed ID: 8113344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterising Non-Structural Protein NS4 of African Horse Sickness Virus.
    Zwart L; Potgieter CA; Clift SJ; van Staden V
    PLoS One; 2015; 10(4):e0124281. PubMed ID: 25915516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A bluetongue serogroup-reactive epitope in the amino terminal half of the major core protein VP7 is accessible on the surface of bluetongue virus particles.
    Eaton BT; Gould AR; Hyatt AD; Coupar BE; Martyn JC; White JR
    Virology; 1991 Feb; 180(2):687-96. PubMed ID: 1703371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.